HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oligoclonal bands and MRI in clinically isolated syndromes: predicting conversion time to multiple sclerosis.

Abstract
The objective of the study was to evaluate whether the presence of oligoclonal bands (OB) adds information in predicting CIS conversion to clinical definite multiple sclerosis (CDMS) and conversion time to CDMS. From 1998 to 2006, CIS patients were included in a prospective study. Patients underwent brain MRI and OB determination within 2 months of the first demyelinating event. We analyzed conversion to CDMS and time to conversion to CDMS according to abnormal MRI and the presence of OB. Forty patients were included. Fifteen patients (37%) converted to CDMS; 14 of them (93.3%) had abnormal baseline MRI (P = 0.01, RR = 5.9; 95% CI 1.3-10.1) and 13 (86.7%) had positive OB in CSF (P = <0.01, RR = 5.3; 95% CI 1.6-9.5). The risk of conversion to CDMS in patients with positive OB and abnormal baseline MRI was significantly higher compared to patients negative for both tests or with only one positive (RR = 9.1; 95% CI 3.5-14.6). Time to conversion to CDMS was 6.8 +/- 3.5 months for patients with OB and abnormal baseline MRI and 19 +/- 14 months for patients with only one abnormal test. CIS patients with abnormal baseline OB in CSF have a higher risk for developing CDMS. Regarding conversion time to CDMS, when abnormal MRI was added to positive OB, patients converted faster (mean time, 6 vs. 19 months). This information may be useful when considering treatment in CIS patients.
AuthorsRojas Juan Ignacio, Patrucco Liliana, Cristiano Edgardo
JournalJournal of neurology (J Neurol) Vol. 257 Issue 7 Pg. 1188-91 (Jul 2010) ISSN: 1432-1459 [Electronic] Germany
PMID20157721 (Publication Type: Journal Article)
Chemical References
  • Oligoclonal Bands
Topics
  • Adult
  • Cerebrospinal Fluid (chemistry)
  • Disease Progression
  • Female
  • Humans
  • Isoelectric Focusing (methods)
  • Kaplan-Meier Estimate
  • Magnetic Resonance Imaging (methods)
  • Male
  • Multiple Sclerosis (cerebrospinal fluid, diagnosis, pathology)
  • Oligoclonal Bands (isolation & purification, metabolism)
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Risk Factors
  • Syndrome
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: